RÉSUMÉ
Hypertrophic pachymeningitis (HP) is a rare disorder marked by thickening of the dura mater due to diverse etiologies. MPO-ANCA-positive HP represents a variant of AAV confined to the central nervous system, distinguished by the presence of serum MPO antibodies. Distinguishing HP triggered by MPO-ANCA from other causes can be challenging.In this study, we present two cases of MPO-ANCA-positive HP initially misdiagnosed as intracranial infections. Case 1 underwent surgery for chronic suppurative otitis media, with histopathological findings revealing inflammatory changes without definitive suppuration. He was presumed to have a secondary intracranial infection resulting from the surgery. However, his condition deteriorated despite two weeks of antibiotic and antiviral treatment. Case 2 presented with headache and was initially suspected of having intracranial Brucellosis given his serum Brucella positivity. Despite treatment for brucellosis, his symptoms persisted, and he developed visual and hearing impairments. Both patients were ultimately diagnosed with MPO-ANCA-positive HP, exhibiting serum MPO antibody positivity. Their symptoms showed improvement with glucocorticoid and immunosuppressive therapy.Based on these observations, we propose that MPO-ANCA-positive HP may initially present as intracranial infection. For HP patients presenting with headache, mastoiditis, otitis media, and visual loss, it is imperative to conduct ANCA antibody-related tests to enhance diagnostic precision.
Sujet(s)
Anticorps anti-cytoplasme des polynucléaires neutrophiles , Méningite , Humains , Mâle , Méningite/diagnostic , Méningite/immunologie , Anticorps anti-cytoplasme des polynucléaires neutrophiles/sang , Diagnostic différentiel , Adulte d'âge moyen , Myeloperoxidase/immunologie , Hypertrophie/diagnostic , Adulte , Brucellose/diagnostic , Brucellose/complicationsRÉSUMÉ
BACKGROUND: Extraparenchymal neurocysticercosis (NCC) commonly presents with symptoms of raised intracranial pressure such as headache, nausea, vomiting, or delirium. Intraventricular NCC is frequently associated with obstructive hydrocephalus as well as recurrent inflammatory cascade leading to chronic meningitis. OBJECTIVE: The aim of this study was to report the novel use and benefit of B cell depleting therapy in a case of treatment-refractory cysticercal meningoencephalitis. CASE: In this article, we report about a young male with intraventricular NCC, who had recurrent meningitis (with encephalitis) and kept relapsing despite multiple cerebrospinal fluid diversion procedures, cysticidal therapy, and high-dose steroids. He finally showed clinical and radiological resolution with pulsed rituximab therapy. CONCLUSION: This off-label use of a monoclonal antibody against CD20 may be considered as a rescue therapy in steroid-refractory immune-mediated cysticercal meningitis.
Sujet(s)
Neurocysticercose , Humains , Mâle , Neurocysticercose/complications , Neurocysticercose/immunologie , Rituximab/usage thérapeutique , Méningite/immunologie , Méningite/traitement médicamenteux , Méningite/thérapie , Lymphocytes B/immunologie , Facteurs immunologiques/usage thérapeutique , AdulteSujet(s)
Erreurs de diagnostic , Imagerie par résonance magnétique , Méningiome , Méningite , Humains , Méningite/diagnostic , Méningite/sang , Méningite/immunologie , Méningiome/diagnostic , Méningiome/imagerie diagnostique , Immunoglobuline G/sang , Tumeurs des méninges/diagnostic , Tumeurs des méninges/imagerie diagnostique , Mâle , Femelle , Adulte d'âge moyen , HypertrophieRÉSUMÉ
O registro de três surtos de meningite meningocócica tipo C em 2022 na capital paulista, e o crescimento recente de casos e óbitos pela doença em outras localidades do país, acendem um alerta sobre a necessidade de redobrar os esforços de prevenção
Sujet(s)
Méningite/immunologie , Couverture vaccinale , VaccinsRÉSUMÉ
O Calendário Nacional de Vacinação contempla todas as fases da vida. No último mês, houve confirmação de surto no estado de São Paulo, com cinco casos da doença meningocócica (DM) do sorogrupo C, a mais frequente no Brasil entre as meningites bacterianas.
Sujet(s)
Méningite/immunologie , Vaccination , Vaccin BCGRÉSUMÉ
Complement deficient patients are susceptible to rare meningococcal serogroups. A 6-year-old girl presented with serogroup Z meningitis. This led to identification of a C8 deficiency. The MenB-4C vaccine induced cross-reactive antibodies to serogroup Z and increased in vitro opsonophagocytic killing and may thus protect complement deficient patients.
Sujet(s)
Complément C8/déficit , Protection croisée/immunologie , Méningite/microbiologie , Vaccins antiméningococciques/immunologie , Neisseria meningitidis/immunologie , Sérogroupe , Anticorps antibactériens/immunologie , Enfant , Réactions croisées/immunologie , Femelle , Déficits héréditaires en complément , Humains , Méningite/diagnostic , Méningite/immunologie , Infections à méningocoques/prévention et contrôle , Vaccins antiméningococciques/administration et posologie , Neisseria meningitidis/classification , OpsonisationSujet(s)
Immunoglobuline G , Tumeurs des méninges/diagnostic , Méningiome/diagnostic , Méningite/diagnostic , Fosse crânienne postérieure , Humains , Imagerie par résonance magnétique , Mâle , Tumeurs des méninges/imagerie diagnostique , Tumeurs des méninges/immunologie , Méningiome/imagerie diagnostique , Méningiome/immunologie , Méningite/imagerie diagnostique , Méningite/immunologie , Adulte d'âge moyenRÉSUMÉ
Data on the immune response to West Nile virus (WNV) are limited. We analyzed the antiviral cytokine response in serum and cerebrospinal fluid (CSF) samples of patients with WNV fever and WNV neuroinvasive disease using a multiplex bead-based assay for the simultaneous quantification of 13 human cytokines. The panel included cytokines associated with innate and early pro-inflammatory immune responses (TNF-α/IL-6), Th1 (IL-2/IFN-γ), Th2 (IL-4/IL-5/IL-9/IL-13), Th17 immune response (IL-17A/IL-17F/IL-21/IL-22) and the key anti-inflammatory cytokine IL-10. Elevated levels of IFN-γ were detected in 71.7% of CSF and 22.7% of serum samples (p = 0.003). Expression of IL-2/IL-4/TNF-α and Th1 17 cytokines (IL-17A/IL-17F/IL-21) was detected in the serum but not in the CSF (except one positive CSF sample for IL-17F/IL-4). While IL-6 levels were markedly higher in the CSF compared to serum (CSF median 2036.71, IQR 213.82-6190.50; serum median 24.48, IQR 11.93-49.81; p < 0.001), no difference in the IL-13/IL-9/IL-10/IFN-γ/IL-22 levels in serum/CSF was found. In conclusion, increased concentrations of the key cytokines associated with innate and early acute phase responses (IL-6) and Th1 type immune responses (IFN-γ) were found in the CNS of patients with WNV infection. In contrast, expression of the key T-cell growth factor IL-2, Th17 cytokines, a Th2 cytokine IL-4 and the proinflammatory cytokine TNF-α appear to be concentrated mainly in the periphery.
Sujet(s)
Cytokines/liquide cérébrospinal , Méningite/immunologie , Méningoencéphalite/immunologie , Fièvre à virus West Nile/immunologie , Virus du Nil occidental/immunologie , Sujet âgé , Cytokines/sang , Cytokines/immunologie , Femelle , Humains , Interleukine-17/sang , Interleukine-17/liquide cérébrospinal , Interleukine-17/immunologie , Interleukine-4/sang , Interleukine-4/liquide cérébrospinal , Interleukine-4/immunologie , Mâle , Méningite/sang , Méningite/liquide cérébrospinal , Méningite/virologie , Méningoencéphalite/sang , Méningoencéphalite/liquide cérébrospinal , Méningoencéphalite/virologie , Adulte d'âge moyen , Cellules Th17/immunologie , Fièvre à virus West Nile/génétique , Fièvre à virus West Nile/virologie , Virus du Nil occidental/génétique , Virus du Nil occidental/physiologieRÉSUMÉ
RATIONALE: Idiopathic hypertrophic pachymeningitis (IHP) is a rare neurological disorder without a definite etiology. Diagnosis is mainly based on exclusion of other etiologies. PATIENT CONCERNS: A 41-year-old male patient presented with insidious onset headache of 3-month duration. DIAGNOSES: Contrast-enhanced brain magnetic resonance imaging (MRI) revealed diffuse pachymeningeal enhancement over bilateral cerebral hemispheres and the tentorium cerebelli. Lumbar puncture showed increased pressure, lymphocytic pleocytosis, and elevated protein level with normal glucose concentration. Blood tests detected elevated erythrocyte sedimentation rate (ESR) and C-reactive protein. Pathological examination of the dura mater from the right frontal convexity disclosed coarse collagenous deposition with focal lymphoid aggregation. After malignancy and infectious etiologies were excluded, a diagnosis of IHP was made. INTERVENTIONS: Oral prednisolone and azathioprine followed by methotrexate were administered. OUTCOMES: During the 7-year follow-up period, although the patient was not totally headache-free, medical therapy significantly reduced the severity of headache. Follow-up MRI studies showed a reduction in meningeal enhancement and serial ESR measurements revealed a trend of improvement. LESSONS: Methotrexate therapy may be considered in cases of steroid-resistant IHP. In addition to clinical evaluation, serial ESR testing may be considered to guide the treatment strategy and assess the response to therapy.
Sujet(s)
Anticorps anticardiolipines/immunologie , Céphalée/immunologie , Hypertrophie/immunologie , Méningite/immunologie , Adulte , Encéphale/immunologie , Encéphale/anatomopathologie , Dure-mère/immunologie , Dure-mère/anatomopathologie , Humains , MâleRÉSUMÉ
BACKGROUND: Dural thickening is observed in lymphoma, dural carcinomatosis, meningioma, tuberculosis, and autoimmune diseases. We encountered a patient with dural thickening and complaints of neck and back pain, numbness and loss of strength in the hands. The patient also suffered from polychondritis and had previously received steroid and methotrexate treatment for this indication. The patients' serum was also positive for ANA, yet she did not have any other findings suggesting lupus. Our radiological and pathological analysis revealed IHSP (IgG4-related hypertrophic sclerosing pachymeningitis). In this review study, we provided a detailed literature survey to increase the awareness about IHSP in the neurosurgical community. METHODS: MRI (magnetic resonance imaging)-based radiological analyses revealed a posterior extramedullary spinal mass extending from C2 to T2-T3 level. The dural mass was surgically excised and a broad panel of immunohistochemical markers including S100, EMA, CD246/ALK-1, CD45, CD20, CD79a, CD138, CD68, CD1a and CD34 was studied. Immunoglobulin heavy chain/kappa chain gene rearrangement analysis was performed which ruled out a lymphoproliferative disorder. RESULTS: MRI and pathological findings suggested IHSP. As the disease relapsed with a new anterior extramedullary multilobulated lesion extending from C5 to T1 level, the patient is now closely monitored for further medical and surgical treatment. CONCLUSIONS: IHSP is a relatively novel entity of hypertrophic pachymeningitis and should be included in the differential diagnosis of dural thickening. The fibrosis accompanying IHSP may not respond to medical treatment, which includes steroids and immunosuppressive agents. Additionally, neurological deficits, seizures, spinal decompression, hydrocephalus, or brainstem compression necessitate early surgical intervention. A continued vigilance is also necessary as the disease may relapse long-term following surgical treatment.
Sujet(s)
Hypertrophie/diagnostic , Immunoglobuline G/immunologie , Méningite/diagnostic , Récidive tumorale locale/diagnostic , Maladies auto-immunes/diagnostic , Maladies auto-immunes/immunologie , Diagnostic différentiel , Humains , Hypertrophie/immunologie , Hypertrophie/chirurgie , Méningite/immunologie , Méningite/chirurgie , Récidive tumorale locale/immunologie , Récidive tumorale locale/chirurgieRÉSUMÉ
We report the case of a 70-year-old Japanese man who was referred from a local urologist because of acute urinary retention (detrusor underactivity revealed by a urodynamics examination). A neurogenic urinary retention workup failed to reveal the aetiology, but a spinal tap incidentally showed occult meningeal reaction with positive oligoclonal band. The patient had no headache, nausea/vomiting or fever. Considering his clinical laboratory findings, his neural lesions seemed to involve the meninges and spinal cord, suggestive of 'form fruste' meningitis-retention syndrome. When clinicians encounter patients with urinary retention of undetermined aetiology, a spinal tap should be considered.
Sujet(s)
Méningite/complications , Ponction lombaire/méthodes , Rétention d'urine/étiologie , Post-cure , Sujet âgé , Asiatiques/ethnologie , Humains , Mâle , Méninges/anatomopathologie , Méningite/liquide cérébrospinal , Méningite/immunologie , Bandes oligoclonales/liquide cérébrospinal , Moelle spinale/anatomopathologie , Hypoactivité vésicale/diagnostic , Hypoactivité vésicale/physiopathologie , UrodynamiqueRÉSUMÉ
BACKGROUND: Spinal immunoglobulin G4-related hypertrophic pachymeningitis (IgG4-HP) is a rare disease. Little information is known regarding the diagnosis, management, and prognosis of patients with spinal IgG4-HP. METHODS: The authors present a case of spinal IgG4-HP with a systematic review of the literature according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Relevant studies (up to April 2020) that reported patients with spinal IgG4-HP, based on the criteria of Japan College of Rheumatology, were identified from the PubMed and Cochrane Library databases. RESULTS: This systematic review identified 33 patients, including the present case, of whom 21 were male and 12 were female. The mean value of age was 51.2 (±12.6) years. Eight patients had systemic involvement. In addition, among 33 patients, 13 patients had an elevated serum IgG4. Surgery was performed in 31 patients. Steroid therapy alone and steroid therapy with immunosuppressants were effective in 94% and 100% of the cases, respectively. Furthermore, 31 of 33 patients reported improved outcomes, 1 patient died due to infection, and in 2 patients the data were not available. CONCLUSIONS: Spinal IgG4-HP is a rare entity. In addition, it should be considered in the differential diagnosis of space-occupying lesions around the spinal cord. Histopathology with immunohistochemistry results provides the most reliable evidence for diagnosis. Steroid therapy is the first line of treatment. Surgical decompression may be required in patients presenting with nerve root and/or spinal cord compression. Long-term follow-up is necessary for patients with spinal IgG4-HP.
Sujet(s)
Maladie associée aux immunoglobulines G4/complications , Méningite/immunologie , Maladies de la moelle épinière/immunologie , Adulte , Sujet âgé , Femelle , Humains , Maladie associée aux immunoglobulines G4/anatomopathologie , Mâle , Méningite/anatomopathologie , Adulte d'âge moyen , Maladies de la moelle épinière/anatomopathologie , Jeune adulteRÉSUMÉ
Varicella-zoster virus vaccination is recommended for virtually all young children in the United States, Canada, and several other countries. Varicella vaccine is a live attenuated virus that retains some of its neurotropic properties. Herpes zoster caused by vaccine virus still occurs in immunized children, although the rate is much lower than in children who had wild-type varicella. It was commonly thought that 2 varicella vaccinations would protect children against the most serious complication of meningitis following herpes zoster; however, 2 meningitis cases have already been published. We now report a third case of varicella vaccine meningitis and define risk factors shared by all 3 immunized adolescents. The diagnosis in cerebrospinal fluid in this third case was verified by amplifying and sequencing portions of the viral genome, to document fixed alleles found only in the vaccine strain. Viral antibody was also detected in the cerebrospinal fluid by confocal microscopy. When compared with the other 2 cases, remarkably all 3 were 14 years old when meningitis occurred. All 3 were treated with intravenous acyclovir, with complete recovery. The adolescent in our case report also had recurrent asthma, which was treated with both prednisone tablets and beclomethasone inhaler before onset of meningitis. When the 3 cases were considered together, they suggested that immunity to varicella-zoster virus may be waning sufficiently in some twice-immunized adolescents to make them vulnerable to varicella vaccine virus reactivation and subsequent meningitis. This complication rarely happens in children after wild-type varicella.
Sujet(s)
Vaccin contre la varicelle/effets indésirables , Zona/immunologie , Immunocompétence/immunologie , Méningite/étiologie , Méningite/immunologie , Aciclovir/usage thérapeutique , Adolescent , Antiviraux/usage thérapeutique , Vaccin contre la varicelle/immunologie , Femelle , Humains , Mâle , Méningite/traitement médicamenteux , Valaciclovir/usage thérapeutiqueRÉSUMÉ
BACKGROUND: The clinical spectrum of myelin oligodendrocyte glycoprotein (MOG)-antibody-associated disease is expanding. OBJECTIVE: To describe an unusual case of MOG-antibody-associated hypertrophic pachymeningitis (HP). METHODS: Case study. RESULTS: A 57-year-old female presented with a generalised seizure on a background of 3 months history of progressive cognitive decline and behavioural changes. Brain Magnetic Resonance Imaging (MRI) revealed widespread pachymeningeal enhancement and hyperintense signal in both hippocampi. Cerebrospinal Fluid (CSF) examination was normal. The patient was found positive for MOG-antibody. She clinically improved with steroids and the MRI abnormalities completely resolved. CONCLUSIONS: Clinicians might consider testing for MOG-antibody in cases with HP.
Sujet(s)
Méningite , Glycoprotéine MOG/immunologie , Femelle , Humains , Hypertrophie/anatomopathologie , Imagerie par résonance magnétique , Méningite/diagnostic , Méningite/immunologie , Méningite/anatomopathologie , Méningite/physiopathologie , Adulte d'âge moyenSujet(s)
Maladies démyélinisantes auto-immunes du SNC/imagerie diagnostique , Immunoglobuline G/immunologie , Méningite/imagerie diagnostique , Méningite/immunologie , Glycoprotéine MOG/immunologie , Autoanticorps/sang , Autoanticorps/immunologie , Autoantigènes/immunologie , Enfant , Maladies démyélinisantes auto-immunes du SNC/immunologie , Femelle , Humains , Immunoglobuline G/sang , Imagerie par résonance magnétique , Mâle , Névrite optique/imagerie diagnostique , Névrite optique/immunologieSujet(s)
Infections à virus Epstein-Barr/virologie , Fièvre/virologie , Herpèsvirus humain de type 4/pathogénicité , Hypertension intracrânienne/virologie , Méningite/virologie , Aciclovir/usage thérapeutique , Adulte , Dexaméthasone/usage thérapeutique , Diagnostic différentiel , Infections à virus Epstein-Barr/imagerie diagnostique , Infections à virus Epstein-Barr/traitement médicamenteux , Infections à virus Epstein-Barr/immunologie , Femelle , Fièvre/imagerie diagnostique , Fièvre/traitement médicamenteux , Fièvre/immunologie , Glucose/liquide cérébrospinal , Herpèsvirus humain de type 4/immunologie , Humains , Immunocompétence , Hypertension intracrânienne/imagerie diagnostique , Hypertension intracrânienne/traitement médicamenteux , Hypertension intracrânienne/immunologie , Méningite/imagerie diagnostique , Méningite/traitement médicamenteux , Méningite/immunologie , Monocytes/anatomopathologie , Monocytes/virologie , Crâne/imagerie diagnostique , Crâne/effets des médicaments et des substances chimiques , Crâne/immunologie , Crâne/virologieRÉSUMÉ
OBJECTIVE: To report a schistosomal myeloradiculopathy case in a non-endemic area. CASE DESCRIPTION: A previously healthy 11-year-old boy, stricken by an acute loss of strength on his lower limbs, followed by a loss of strength on his upper limbs and upper body, associated with altered sensitivity of the vesical globe formation. The patient's cerebrospinal fluid analysis showed eosinophilic meningitis, in addition to peripheral eosinophilia. The investigation resulted in a positive serology for Schistosoma mansoni. The treatment included steroids and praziquantel 60mg/kg, with a new dose after a month, as well as physical therapy for rehabilitation. The patient evolved with clinical improvement in the neurological exam, with a medullary section initially at C6, but now at T6. The patient is kept at prednisolone use (30mg/day) and longterm urinary catheter dependence. COMMENTS: The schistosomiasis is endemic in many regions of Brazil; however, it has low incidence in the south of the country. Among its main manifestations, the schistosomal myeloradiculopathy is the most severe ectopic form of the disease, and should be suspected in patients with low back pain, strength and/or sensibility disorder of the lower limbs or urinary tract's disturbance. Early diagnosis and treatment should be done in order to reduce severe neurological sequelae. Treatment includes schistosomiasis drugs, corticosteroids and/or surgery.
Sujet(s)
Schistosomiase du système nerveux central/diagnostic , Schistosomiase du système nerveux central/parasitologie , Schistosoma mansoni/isolement et purification , Animaux , Anthelminthiques/administration et posologie , Anthelminthiques/usage thérapeutique , Brésil/épidémiologie , Enfant , Association de médicaments , Éosinophilie/liquide cérébrospinal , Humains , Mâle , Méningite/immunologie , Schistosomiase du système nerveux central/traitement médicamenteux , Schistosomiase du système nerveux central/rééducation et réadaptation , Praziquantel/administration et posologie , Praziquantel/usage thérapeutique , Schistosoma mansoni/immunologie , Stéroïdes/administration et posologie , Stéroïdes/usage thérapeutique , Résultat thérapeutiqueRÉSUMÉ
BACKGROUND: Angiostrongylus cantonensis is an important etiologic agent of eosinophilic meningitis and/or eosinophilic meningoencephalitis in humans. Th2 responses have been considered to be predominant in non-permissive hosts. However, changes of cytokines in the central nervous system of the host remain unclear. The present study was conducted to determine the temporal-spatial expressions of IL-4, IL-10, and IL-13 in the brains of infected C57BL/6 and BALB/c mice by immunohistochemistry. METHODS: After infecting each mouse with 25 third-stage larvae (L3), brain specimens were collected on day 7 and day 28 post-infection. Each specimen was cut into five sections and stained with corresponding antibodies of the three cytokines. RESULTS: In infected C57BL/6 mice, high IL-4 expressions were found in the isocortex, IL-10 in the isocortex, olfactory area, hippocampus, cerebral nuclei, hypothalamus, cerebellum nuclei, and medulla, and IL-13 in the isocortex and cerebellum. In infected BALB/c mice, IL-4 and IL-10 were highly expressed in the isocortex, olfactory areas, cerebral nuclei, hypothalamus, and cerebellum nuclei and IL-13 in the thalamus and hypothalamus. High levels of the cytokines were usually detected in on day 7 in BALB/c mice and day 28 in C57BL/6 mice. CONCLUSION: The special temporal-spatial expression changes of these three cytokines in the infected mouse brain may explain the differences in the survival and the time of occurrence of immune responses in the hosts after A. cantonensis infection.
Sujet(s)
Encéphale/immunologie , Encéphale/parasitologie , Interleukine-10/génétique , Interleukine-13/génétique , Interleukine-4/génétique , Infections à Strongylida/immunologie , Angiostrongylus cantonensis , Animaux , Modèles animaux de maladie humaine , Immunohistochimie , Méningite/immunologie , Méningite/parasitologie , Souris , Souris de lignée BALB C , Souris de lignée C57BL , Analyse spatio-temporelleRÉSUMÉ
ABSTRACT Objective: To report a schistosomal myeloradiculopathy case in a non-endemic area. Case description: A previously healthy 11-year-old boy, stricken by an acute loss of strength on his lower limbs, followed by a loss of strength on his upper limbs and upper body, associated with altered sensitivity of the vesical globe formation. The patient's cerebrospinal fluid analysis showed eosinophilic meningitis, in addition to peripheral eosinophilia. The investigation resulted in a positive serology for Schistosoma mansoni. The treatment included steroids and praziquantel 60mg/kg, with a new dose after a month, as well as physical therapy for rehabilitation. The patient evolved with clinical improvement in the neurological exam, with a medullary section initially at C6, but now at T6. The patient is kept at prednisolone use (30mg/day) and longterm urinary catheter dependence. Comments: The schistosomiasis is endemic in many regions of Brazil; however, it has low incidence in the south of the country. Among its main manifestations, the schistosomal myeloradiculopathy is the most severe ectopic form of the disease, and should be suspected in patients with low back pain, strength and/or sensibility disorder of the lower limbs or urinary tract's disturbance. Early diagnosis and treatment should be done in order to reduce severe neurological sequelae. Treatment includes schistosomiasis drugs, corticosteroids and/or surgery.
RESUMO Objetivo: Relatar um caso de mielorradiculopatia esquistossomótica em área não endêmica. Descrição do caso: Paciente do sexo masculino, 11 anos, previamente hígido, com história aguda de paresia de membros inferiores, que evoluiu para membros superiores e tronco, associada à alteração de sensibilidade e formação de globo vesical. O exame do líquor demonstrava meningite eosinofílica, além de eosinofilia periférica. A investigação resultou em sorologia positiva para Schistosoma mansoni. O tratamento foi realizado com corticoterapia e praziquantel 60 mg/kg, com nova dose após um mês, além de fisioterapia para reabilitação. Evoluiu com melhora clínica no exame neurológico, com nível de secção medular que inicialmente correspondia a C6, encontrando-se atualmente em T6. Mantém uso de prednisolona 30 mg/dia e dependência de sonda vesical de demora. Comentários: A esquistossomose é uma doença endêmica em muitas regiões do Brasil, porém com pouca incidência no Sul do país. Dentre as principais manifestações, a mielorradiculopatia esquistossomótica é a forma ectópica mais grave e deve ser suspeitada na vigência de dor lombar, alteração de força e/ ou sensibilidade de membros inferiores e distúrbio urinário. O diagnóstico e o tratamento devem ser instituídos precocemente para diminuir o risco de sequelas neurológicas graves. O tratamento pode ser realizado com esquistossomicidas, corticosteroides e/ ou cirurgia.
Sujet(s)
Schistosoma mansoni/isolement et purification , Schistosomiase du système nerveux central/diagnostic , Schistosomiase du système nerveux central/parasitologie , Praziquantel/administration et posologie , Praziquantel/usage thérapeutique , Schistosoma mansoni/immunologie , Stéroïdes/administration et posologie , Stéroïdes/usage thérapeutique , Brésil/épidémiologie , Résultat thérapeutique , Schistosomiase du système nerveux central/traitement médicamenteux , Schistosomiase du système nerveux central/rééducation et réadaptation , Association de médicaments , Éosinophilie/liquide cérébrospinal , Méningite/immunologie , Anthelminthiques/administration et posologie , Anthelminthiques/usage thérapeutiqueRÉSUMÉ
Antecedentes y objetivo: El riesgo de meningitis bacteriana aumenta en los pacientes con implante coclear. Por ello, se indica la vacunación antineumocócica, antigripal y frente a Haemophilus influenzae tipo b en este grupo. El objetivo del presente estudio es conocer el cumplimiento del calendario vacunal en los pacientes implantados en un hospital de referencia. Materiales y métodos: Se incluyeron los pacientes con implante coclear intervenidos entre 2005 y 2015. Se evaluaron las coberturas vacunales frente a gripe estacional, Haemophilus influenzae tipo b, neumococo conjugada de 13 serotipos y neumococo polisacárida de 23 serotipos. Se dividió la muestra en 2 grupos por edad (< 14 años y ≥ 14 años). Se realizó un análisis univariante y bivariante. Resultados: De los 153 pacientes estudiados (28,01% 0-13 años y 71,9% ≥ 14), solo 2 (5,71%) tuvieron un 100% de adherencia al calendario vacunal, mientras que el 65,71% registró un cumplimiento del 50% o menor. Globalmente, la cobertura de vacunación frente a la pauta secuencial de neumococo fue del 48,57%. La población pediátrica superó el 90% de cobertura para la vacuna frente a Haemophilus influenzae tipo b y neumococo conjugada de 13 serotipos, mientras que en los mayores de 14 años apenas superó el 50%. La cobertura frente a gripe estacional fue inferior al 40%. Se obtuvo una correlación inversa entre la edad y el cumplimiento, aunque no estadísticamente significativa. Conclusiones. Las coberturas de vacunación en los pacientes con implante coclear evaluados son más bajas de lo esperado. Se propone la colaboración estrecha entre los servicios de Otorrinolaringología y las Unidades de Vacunas como principal estrategia para la mejora
Background and objective: The risk of bacterial meningitis increases in cochlear implant patients. Therefore, pneumococcal, influenza and Haemophilus influenzae type b vaccination is indicated in this group. The aim of this study was to determine compliance with the vaccination calendar in patients implanted in a referral hospital. Materials and methods: Patients with cochlear implant operated between 2005 and 2015 were included. Vaccine coverage for seasonal influenza, Haemophilus influenzae type b and pneumococcal conjugate 13-serotypes and pneumococcal polysaccharide 23-serotypes was evaluated. The sample was divided into 2 age groups (< 14 years and ≥ 14 years). A univariate and bivariate analysis was performed. Results: Of the 153 patients studied (28.01% 0-13 years old and 71.9% ≥ 14), only 2 (5.71%) had 100% adherence to the vaccination schedule, while 65.71% had compliance of 50% or less. Overall, vaccination coverage against the sequential pneumococcal pattern was 48.57%. The paediatric population exceeded 90% coverage for the vaccine against Haemophilus influenzae type b and pneumococcal conjugate 13-serotypes while in those over 14 years of age it barely exceeded 50%. Influenza coverage was less than 40%. An inverse correlation was obtained between age and compliance, although not statistically significant. Conclusions: Vaccination coverage in patients with cochlear implant is lower than expected. Close collaboration between Otolaryngology departments and the Vaccination Units is proposed as the main strategy for improvement